On December 26, 2023, Shanghai Vcanbio Jisheng Cell Technology Co., Ltd. closed the transaction. The company's registered capital increased by CNY 20 million post-completion of the transaction.
Vcanbio Cell & Gene Engineering Corp., Ltd
Equities
600645
CNE000000545
Medical Equipment, Supplies & Distribution
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
16.38 CNY | -1.92% | -2.62% | -19.19% |
1st Jan change | Capi. | |
---|---|---|
-19.19% | 1.04B | |
-10.93% | 11.34B | |
-11.84% | 7.46B | |
+31.42% | 5.65B | |
+4.38% | 5.56B | |
-17.33% | 3.77B | |
+7.01% | 2.57B | |
-64.33% | 2.39B | |
-10.17% | 2.26B | |
+24.35% | 2.15B |
- Stock Market
- Equities
- 600645 Stock
- News Vcanbio Cell & Gene Engineering Corp., Ltd
- Shanghai Vcanbio Jisheng Cell Technology Co., Ltd. announced that it has received CNY 20 million in funding from Vcanbio Cell & Gene Engineering Corp., Ltd